Search

Jae Young Lee

Examiner (ID: 3738, Phone: (571)270-3936 , Office: P/2466 )

Most Active Art Unit
2466
Art Unit(s)
2466, 2479, 2419, 4144, 2619
Total Applications
845
Issued Applications
651
Pending Applications
17
Abandoned Applications
180

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6479572 [patent_doc_number] => 20100041741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'SUPPRESSION OF MITOCHONDRIAL OXIDATIVE STRESS' [patent_app_type] => utility [patent_app_number] => 12/446878 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23855 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041741.pdf [firstpage_image] =>[orig_patent_app_number] => 12446878 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/446878
SUPPRESSION OF MITOCHONDRIAL OXIDATIVE STRESS Oct 18, 2007 Abandoned
Array ( [id] => 102240 [patent_doc_number] => 07723055 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Diagnosing and treating hematopoietic cancers' [patent_app_type] => utility [patent_app_number] => 11/874703 [patent_app_country] => US [patent_app_date] => 2007-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 37 [patent_no_of_words] => 20925 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723055.pdf [firstpage_image] =>[orig_patent_app_number] => 11874703 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/874703
Diagnosing and treating hematopoietic cancers Oct 17, 2007 Issued
Array ( [id] => 5485877 [patent_doc_number] => 20090275642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'DNA COMPOSITION FOR ELICITING AN IMMUNE RESPONSE AGAINST TUMOR-ASSOCIATED MACROPHAGES' [patent_app_type] => utility [patent_app_number] => 12/311379 [patent_app_country] => US [patent_app_date] => 2007-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15923 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275642.pdf [firstpage_image] =>[orig_patent_app_number] => 12311379 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/311379
DNA COMPOSITION FOR ELICITING AN IMMUNE RESPONSE AGAINST TUMOR-ASSOCIATED MACROPHAGES Oct 4, 2007 Abandoned
Array ( [id] => 5428585 [patent_doc_number] => 20090087895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'EXPRESSION VECTORS FOR PRODUCING TAG-CLEAVABLE FUSION PROTEINS IN MULTIPLE EXPRESSION SYSTEMS' [patent_app_type] => utility [patent_app_number] => 11/862900 [patent_app_country] => US [patent_app_date] => 2007-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 5495 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087895.pdf [firstpage_image] =>[orig_patent_app_number] => 11862900 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/862900
Kit for producing recombinant tag-cleavable fusion proteins via at least two different expression vectors allow protein production in two different species host cells Sep 26, 2007 Issued
Array ( [id] => 4765108 [patent_doc_number] => 20080176319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Methods and compositions for modulating apoptotic pathways' [patent_app_type] => utility [patent_app_number] => 11/901314 [patent_app_country] => US [patent_app_date] => 2007-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20152 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176319.pdf [firstpage_image] =>[orig_patent_app_number] => 11901314 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/901314
Methods and compositions for modulating apoptotic pathways Sep 16, 2007 Abandoned
Array ( [id] => 6024213 [patent_doc_number] => 20110052539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'ONCOLYTIC RHABDOVIRUS' [patent_app_type] => utility [patent_app_number] => 12/441494 [patent_app_country] => US [patent_app_date] => 2007-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 33916 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052539.pdf [firstpage_image] =>[orig_patent_app_number] => 12441494 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/441494
Oncolytic rhabdovirus Sep 16, 2007 Issued
Array ( [id] => 4772612 [patent_doc_number] => 20080058271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Prevention of primary sjogren\' s Syndrome by ICA69 deficiency' [patent_app_type] => utility [patent_app_number] => 11/895892 [patent_app_country] => US [patent_app_date] => 2007-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7872 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058271.pdf [firstpage_image] =>[orig_patent_app_number] => 11895892 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/895892
Prevention of primary sjogren' s Syndrome by ICA69 deficiency Aug 27, 2007 Abandoned
Array ( [id] => 4771922 [patent_doc_number] => 20080057580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Method of differentiation induction to osteoblasts' [patent_app_type] => utility [patent_app_number] => 11/892061 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10172 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057580.pdf [firstpage_image] =>[orig_patent_app_number] => 11892061 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/892061
Method of differentiation induction to osteoblasts Aug 19, 2007 Issued
Array ( [id] => 6615959 [patent_doc_number] => 20100003224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Combination Therapy' [patent_app_type] => utility [patent_app_number] => 12/375987 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25628 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003224.pdf [firstpage_image] =>[orig_patent_app_number] => 12375987 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/375987
Combination Therapy Aug 1, 2007 Abandoned
Array ( [id] => 4939411 [patent_doc_number] => 20080076730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'EXTENDED ANTEGRADE EPICARDIAL CORONARY INFUSION OF ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY' [patent_app_type] => utility [patent_app_number] => 11/778900 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18994 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076730.pdf [firstpage_image] =>[orig_patent_app_number] => 11778900 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/778900
EXTENDED ANTEGRADE EPICARDIAL CORONARY INFUSION OF ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY Jul 16, 2007 Abandoned
Array ( [id] => 6513710 [patent_doc_number] => 20100011450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'IMMUNODEFICIENT MICE TRANSGENIC FOR HLA CLASS I AND HLA CLASS II MOLECULES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/373373 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10350 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20100011450.pdf [firstpage_image] =>[orig_patent_app_number] => 12373373 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/373373
IMMUNODEFICIENT MICE TRANSGENIC FOR HLA CLASS I AND HLA CLASS II MOLECULES AND THEIR USES Jul 12, 2007 Abandoned
Array ( [id] => 5580546 [patent_doc_number] => 20090175892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes' [patent_app_type] => utility [patent_app_number] => 11/826134 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 17004 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175892.pdf [firstpage_image] =>[orig_patent_app_number] => 11826134 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/826134
Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes Jul 11, 2007 Issued
Array ( [id] => 6475702 [patent_doc_number] => 20100284971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'MODIFIED FACTOR VIII AND FACTOR IX GENES AND VECTORS FOR GENE THERAPY' [patent_app_type] => utility [patent_app_number] => 12/305508 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 10433 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0284/20100284971.pdf [firstpage_image] =>[orig_patent_app_number] => 12305508 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/305508
Modified factor VIII and factor IX genes and vectors for gene therapy Jun 18, 2007 Issued
Array ( [id] => 6009083 [patent_doc_number] => 20110061115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'Lung rpogenitor cells, assays, and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/308351 [patent_app_country] => US [patent_app_date] => 2007-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15828 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20110061115.pdf [firstpage_image] =>[orig_patent_app_number] => 12308351 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/308351
Lung epithelial progenitor cells Jun 17, 2007 Issued
Array ( [id] => 4758864 [patent_doc_number] => 20080311090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Methods for inhibition of proliferative disease, including hepatocellular carcinoma' [patent_app_type] => utility [patent_app_number] => 11/764130 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 7865 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311090.pdf [firstpage_image] =>[orig_patent_app_number] => 11764130 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/764130
Methods for inhibition of proliferative disease, including hepatocellular carcinoma Jun 14, 2007 Abandoned
Array ( [id] => 7692180 [patent_doc_number] => 20070231853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'METHODS OF ISOLATING BIPOTENT HEPATIC PROGENITOR CELLS' [patent_app_type] => utility [patent_app_number] => 11/758593 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11720 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231853.pdf [firstpage_image] =>[orig_patent_app_number] => 11758593 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/758593
METHODS OF ISOLATING BIPOTENT HEPATIC PROGENITOR CELLS Jun 4, 2007 Abandoned
Array ( [id] => 5125901 [patent_doc_number] => 20070238172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'METHODS OF ISOLATING BIPOTENT HEPATIC PROGENITOR CELLS' [patent_app_type] => utility [patent_app_number] => 11/757168 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11720 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238172.pdf [firstpage_image] =>[orig_patent_app_number] => 11757168 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/757168
METHODS OF ISOLATING BIPOTENT HEPATIC PROGENITOR CELLS May 31, 2007 Abandoned
Array ( [id] => 5127964 [patent_doc_number] => 20070240235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'METHODS FOR SUPPORTING AND PRODUCING HUMAN CELLS AND TISSUES IN NON-HUMAN MAMMAL HOSTS' [patent_app_type] => utility [patent_app_number] => 11/754339 [patent_app_country] => US [patent_app_date] => 2007-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21387 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20070240235.pdf [firstpage_image] =>[orig_patent_app_number] => 11754339 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/754339
METHODS FOR SUPPORTING AND PRODUCING HUMAN CELLS AND TISSUES IN NON-HUMAN MAMMAL HOSTS May 27, 2007 Abandoned
Array ( [id] => 4546112 [patent_doc_number] => 07960173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Cardiac conduction system cells and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/753719 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 19 [patent_no_of_words] => 17494 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960173.pdf [firstpage_image] =>[orig_patent_app_number] => 11753719 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/753719
Cardiac conduction system cells and uses thereof May 24, 2007 Issued
Array ( [id] => 4978292 [patent_doc_number] => 20070219526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Restenosis Therapy Using Mesenchymal Stem Cells' [patent_app_type] => utility [patent_app_number] => 11/749522 [patent_app_country] => US [patent_app_date] => 2007-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5451 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219526.pdf [firstpage_image] =>[orig_patent_app_number] => 11749522 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/749522
Restenosis Therapy Using Mesenchymal Stem Cells May 15, 2007 Abandoned
Menu